相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oral Bisphosphonate Use and Risk of Postmenopausal Endometrial Cancer
Polly A. Newcomb et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Protective Effect of Bisphosphonates on Endometrial Cancer Incidence in Data From the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
Sharon Hensley et al.
CANCER (2015)
The effect of bisphosphonates on the risk of endometrial and ovarian malignancies
Gad Rennert et al.
GYNECOLOGIC ONCOLOGY (2014)
Bisphosphonates inactivate human EGFRs to exert antitumor actions
Tony Yuen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer
Agnes Stachnik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Zoledronic acid induces apoptosis and autophagy in cervical cancer cells
I-Te Wang et al.
TUMOR BIOLOGY (2014)
Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case-control studies using two primary-care databases
Y. Vinogradova et al.
BRITISH JOURNAL OF CANCER (2013)
Oral Bisphosphonates and the Risk of Colorectal Cancer A Meta-Analysis
Guorong Yang et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Reduced Risk of Colorectal Cancer With Use of Oral Bisphosphonates: A Systematic Review and Meta-Analysis
Nirav Thosani et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Meta-analysis: oral bisphosphonates and the risk of oesophageal cancer
J. Andrici et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Long Term Bisphosphonate Use in Osteoporotic Patients; A Step Forward, Two Steps Back
Pooneh Salari et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2012)
A Higher Dosage of Oral Alendronate Will Increase the Subsequent Cancer Risk of Osteoporosis Patients in Taiwan: A Population-Based Cohort Study
Wen-Yuan Lee et al.
PLOS ONE (2012)
Bisphosphonates and Risk of Upper Gastrointestinal Cancer - A Case Control Study Using the General Practice Research Database (GPRD)
Ellen Wright et al.
PLOS ONE (2012)
Bisphosphonate use and gastrointestinal tract cancer risk: Meta-analysis of observational studies
Yun Hwan Oh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Bisphosphonates: The first 40 years
R. Graham G. Russell
BONE (2011)
Use of Bisphosphonates and Risk of Breast Cancer
Peter Vestergaard et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
Alendronate and Risk of Esophageal Cancer: A Nationwide Population-Based Study in Taiwan
Yi-Ming Chen et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
Rowan T. Chlebowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Risk of Endometrial Cancer in Relation to Medical Conditions and Medication Use
Joan Fortuny et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Antitumor effects of bisphosphonates: Promising preclinical evidence
Theresa A. Guise
CANCER TREATMENT REVIEWS (2008)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Molecular mechanisms of action of bisphosphonates: Current status
Anke J. Roelofs et al.
CLINICAL CANCER RESEARCH (2006)
Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice
B Ory et al.
CANCER (2005)
Postmenopausal osteoporosis
CJ Rosen
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Bisphosphonates and cancer-induced bone disease:: Beyond their antiresorptive activity
P Clézardin et al.
CANCER RESEARCH (2005)
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis
E Giraudo et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model
T Hiraga et al.
CLINICAL CANCER RESEARCH (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Bisphosphonates induce breast cancer cell death in vitro
O Fromigue et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
Bisphosphonates induce apoptosis in human breast cancer cell lines
SG Senaratne et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
